Creating better animal models for Alpha-1 antitrypsin deficiency

Human Genetic Disease Modeling and Physiology Core

NIH-funded research Univ of Massachusetts Med Sch Worcester · NIH-11146477

This work aims to develop improved animal models to help us understand and find new treatments for Alpha-1 antitrypsin deficiency.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester NIH-funded
Lab location1 site (Worcester, United States)
Project IDNIH-11146477 on NIH RePORTER

What this research studies

To develop effective treatments for Alpha-1 antitrypsin deficiency, we need animal models that accurately show the same problems seen in people with the condition. This project focuses on creating and studying new mouse and ferret models that better mimic the human disease. These models will be used to test potential new therapies, including gene therapy and genome editing, and to set clear goals for how well these treatments should work. By using these improved models, we hope to speed up the discovery of successful therapies for patients.

Who could benefit from this research

Good fit: This foundational work is for patients with Alpha-1 antitrypsin deficiency who may benefit from future advanced therapies developed using these models.

Not a fit: Patients seeking immediate treatment options will not directly benefit from this foundational animal model development.

Why it matters

Potential benefit: If successful, this work could lead to more effective gene therapies and genome editing approaches for Alpha-1 antitrypsin deficiency.

How similar studies have performed: While existing animal models have provided some insights, this work aims to create more accurate and relevant models for testing advanced therapies, representing a novel approach to improving disease modeling.

Where this research is happening

Worcester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.